Works matching IS 17762596 AND DT 2016 AND VI 11 AND IP 5
Results: 12
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of Everolimus.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Combinatorial Study of a Novel Poly (ADP-ribose) Polymerase Inhibitor and an HDAC Inhibitor, SAHA, in Leukemic Cell Lines.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Ceritinib: a Review in ALK-Positive Advanced NSCLC.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article